PRESS RELEASE: Pittsburgh, United States – May, 2024 – SNS Research has published The Digital Health 2024 Market report.
Pittsburgh, PA – May 2024 – A new report by SNS Research projects explosive growth in the digital health market, reaching $243 billion by 2024. This surge is fueled by advancements in telehealth platforms, wearable sensors, and AI-powered solutions that are transforming healthcare delivery. The "Digital Health Market 2024" report analyzes the key trends and opportunities within this rapidly evolving sector.
Digital health is fundamentally reshaping patient care. Innovation in patient portals, intuitive apps, and wearable devices are empowering individuals to manage their health proactively. AI-powered tools offer personalized care, predict health risks, and enhance disease management. Stakeholders investing in robust data infrastructure will unlock insights that improve outcomes and reduce costs. Automation within healthcare workflows promises to increase efficiency, while telehealth breaks down access barriers for patients.
Strategic partnerships with innovators in tech, along with cross-sector alliances are accelerating progress. Success in this landscape requires a proactive approach to evolving regulations, demonstrating data privacy, security, and the efficacy of digital health solutions. Ultimately, a digital-first culture is essential, where the entire healthcare workforce embraces data-driven insights and innovative technology as tools to provide the best possible care.
Driven by the thriving ecosystem, SNS Research estimates that the digital health market will account for more than $243 Billion in 2024 alone. Despite barriers relating to regulation, patient acceptance, and privacy concerns, SNS Research estimates further growth at a CAGR of approximately 14% between 2024 and 2027.
The “Digital Health Market: 2024 - 2030 – Opportunities, Challenges, Strategies & Forecasts” report presents an in-depth assessment of the digital health ecosystem including market drivers, challenges, enabling technologies, applications, key trends, standardization, regulatory landscape, case studies, opportunities, future roadmap, value chain, ecosystem player profiles, and strategies. The report also presents forecasts for digital health investments from 2024 to 2030. The forecasts are segmented for 5 submarkets, 25 use case categories, 5 ecosystem player categories, 6 geographical regions, and 68 countries. The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report.
For Enquiries, quotes and more Info contact us at: [email protected]
The full "Digital Health 2024 Market" report, is available at: https://www.snsresearch.com/digitalhealthmarket
About SNS Research
SNS Research is a global market intelligence and consulting firm with a particular focus on the healthcare and pharmaceutical industries. Our core team is based in Pennsylvania, USA, with industry expert in-house analysts striving to deliver a comprehensive global outlook on a range of topics in the healthcare sector. Trusted by our clients to meet their research needs, we serve organizations of all sizes. Our customers comprise of government agencies, drug manufacturers, biopharmaceutical companies, healthcare providers, educational institutions, international regulatory authorities, and investment firms.
Digital health is fundamentally reshaping patient care. Innovation in patient portals, intuitive apps, and wearable devices are empowering individuals to manage their health proactively. AI-powered tools offer personalized care, predict health risks, and enhance disease management. Stakeholders investing in robust data infrastructure will unlock insights that improve outcomes and reduce costs. Automation within healthcare workflows promises to increase efficiency, while telehealth breaks down access barriers for patients.
Strategic partnerships with innovators in tech, along with cross-sector alliances are accelerating progress. Success in this landscape requires a proactive approach to evolving regulations, demonstrating data privacy, security, and the efficacy of digital health solutions. Ultimately, a digital-first culture is essential, where the entire healthcare workforce embraces data-driven insights and innovative technology as tools to provide the best possible care.
Driven by the thriving ecosystem, SNS Research estimates that the digital health market will account for more than $243 Billion in 2024 alone. Despite barriers relating to regulation, patient acceptance, and privacy concerns, SNS Research estimates further growth at a CAGR of approximately 14% between 2024 and 2027.
The “Digital Health Market: 2024 - 2030 – Opportunities, Challenges, Strategies & Forecasts” report presents an in-depth assessment of the digital health ecosystem including market drivers, challenges, enabling technologies, applications, key trends, standardization, regulatory landscape, case studies, opportunities, future roadmap, value chain, ecosystem player profiles, and strategies. The report also presents forecasts for digital health investments from 2024 to 2030. The forecasts are segmented for 5 submarkets, 25 use case categories, 5 ecosystem player categories, 6 geographical regions, and 68 countries. The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report.
For Enquiries, quotes and more Info contact us at: [email protected]
The full "Digital Health 2024 Market" report, is available at: https://www.snsresearch.com/digitalhealthmarket
About SNS Research
SNS Research is a global market intelligence and consulting firm with a particular focus on the healthcare and pharmaceutical industries. Our core team is based in Pennsylvania, USA, with industry expert in-house analysts striving to deliver a comprehensive global outlook on a range of topics in the healthcare sector. Trusted by our clients to meet their research needs, we serve organizations of all sizes. Our customers comprise of government agencies, drug manufacturers, biopharmaceutical companies, healthcare providers, educational institutions, international regulatory authorities, and investment firms.